Literature DB >> 14283289

FURTHER EVIDENCE FOR THE PRESENCE OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS IN THE RAT.

N E ANDEN, A DAHLSTROEM, K FUXE, K LARSSON.   

Abstract

Entities:  

Keywords:  BRAIN STEM; DOPAMINE; EXPERIMENTAL LAB STUDY; FLUORESCENCE; GANGLIA, BASAL; HISTOCYTOCHEMISTRY; NEURONS; RATS; SUBSTANTIA NIGRA

Mesh:

Substances:

Year:  1965        PMID: 14283289     DOI: 10.1002/aja.1001160117

Source DB:  PubMed          Journal:  Am J Anat        ISSN: 0002-9106


× No keyword cloud information.
  20 in total

1.  Parkinsonism-physiology and pharmacology.

Authors:  D B Calne
Journal:  Br Med J       Date:  1971-09-18

2.  Structure and function of the basal ganglia - a non-clinical view.

Authors:  K E Webster
Journal:  Proc R Soc Med       Date:  1975-04

3.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

4.  Demonstration of nigro-neostriatal tract by degeneration silver method.

Authors:  N Shimizu; S Onishi
Journal:  Exp Brain Res       Date:  1973-04-30       Impact factor: 1.972

5.  Dopamine and adenosinetriphosphatase changes in the corpus striatum of the rat.

Authors:  J G Wood; R E Buckley
Journal:  Experientia       Date:  1973

6.  [The therapeutic effect of L-dopa].

Authors:  P Groneberg; A Struppler
Journal:  Naturwissenschaften       Date:  1972-11

7.  Electron microscopic studies on pigment granules in the substantia nigra and locus coeruleus of the Japanese monkey (Macaca fuscata yakui).

Authors:  K Hirosawa
Journal:  Z Zellforsch Mikrosk Anat       Date:  1968

8.  Reversal of the glabellar reflex in Parkinsonism by L-dopa.

Authors:  H L Klawans; J A Goodwin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-10       Impact factor: 10.154

9.  Alteration of basal ganglia evoked responses by reserpine and L-dopa.

Authors:  W C Koller; C A Berry
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

10.  Levodopa therapy for Parkinsonism in the Shy-Drager syndrome.

Authors:  M J Aminoff; C S Wilcox; M M Woakes; M Kremer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.